Cart
sales@molnova.com
Lomitapide Mesylate
CAS No. 202914-84-9
Lomitapide Mesylate( —— )
Catalog No. M13157 CAS No. 202914-84-9
Lomitapide Mesylate is a potent microsomal triglyceride transfer protein (MTP) inhibitor, used in the treatment of familial hypercholesterolemia.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 84 | In Stock |
|
| 5MG | 56 | In Stock |
|
| 10MG | 92 | In Stock |
|
| 25MG | 140 | In Stock |
|
| 50MG | 221 | In Stock |
|
| 100MG | 333 | In Stock |
|
| 200MG | 491 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLomitapide Mesylate
-
NoteResearch use only, not for human use.
-
Brief DescriptionLomitapide Mesylate is a potent microsomal triglyceride transfer protein (MTP) inhibitor, used in the treatment of familial hypercholesterolemia.
-
DescriptionLomitapide Mesylate is a potent microsomal triglyceride transfer protein (MTP) inhibitor, used in the treatment of familial hypercholesterolemia.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetCETP
-
RecptorMTP
-
Research AreaCardiovascular Disease
-
Indication——
Chemical Information
-
CAS Number202914-84-9
-
Formula Weight789.83
-
Molecular FormulaC40H41F6N3O5S
-
Purity>98% (HPLC)
-
SolubilityEthanol: 100 mg/mL (126.6 mM); DMSO: 100 mg/mL (126.6 mM)
-
SMILESCS(O)(=O)=O.FC(F)(F)CNC(=O)C1(CCCCN2CCC(CC2)NC(=O)C2=CC=CC=C2C2=CC=C(C=C2)C(F)(F)F)C2=CC=CC=C2C2=CC=CC=C12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Davis KA, Miyares MA. Am J Health Syst Pharm. 2014 Jun 15;71(12):1001-8.
molnova catalog
related products
-
Obicetrapib
Obicetrapib (AMG-899, TA-8995, DEX-001) is a potent, ora cholesteryl ester transfer protein (CETP) inhibitor for treatment of dyslipidaemia.
-
Anacetrapib
Anacetrapib (MK 0859) is a potent, orally active cholesteryl ester transfer protein (CETP) inhibitor with IC50 of 7.9 nM and 11.8 nM for rhCETP and C13S CETP mutant, respectively.
-
BMS-212122
BMS-212122 (UNII-0Z473OO6GB) is a potent inhibitor of microsomal triglyceride transfer protein (MTP) and has shown hypolipidemic effects in animal studies.BMS-212122 significantly reduced lipid content and monocyte-derived (CD68+) cells in atherosclerotic plaques.
